Melissa Fore
Internal Medicine · Saint Louis, MONPI 1124380506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,283 and has fallen 79.6% since, to $262 in 2025.
Across 103 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$282
- Pfizer$190
- AbbVie$187
- AstraZeneca$179
- Astellas Pharma US Inc$135
- Johnson & Johnson$123
- plus $834 from 17 others
What the payments were for
- Food & beverage$1,82495%
- Education$1065%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $282 |
| Pfizer | 14 | $190 |
| AbbVie(2 entities) | 10 | $187 |
| AstraZeneca(2 entities) | 9 | $179 |
| Astellas Pharma US Inc | 3 | $135 |
| Johnson & Johnson | 6 | $123 |
| Boehringer Ingelheim | 7 | $122 |
| Inspire Medical Systems, Inc. | 1 | $121 |
| Lilly USA, LLC | 7 | $102 |
| Amgen | 5 | $71 |
| Amarin Pharma, Inc. | 5 | $69 |
| Angiodynamics, Inc. | 1 | $45 |
| Sanofi Pasteur Inc. | 3 | $45 |
| Napo Pharmaceuticals Inc | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $37 |
| GE HealthCare | 2 | $35 |
| Abbott | 2 | $29 |
| GSK | 2 | $27 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Genentech USA, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,930 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 13 | $111 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Saint Louis
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Tracy NorfleetSaint Louis$132K
- Paul OlivoSaint Louis$98K
- William SummersSaint Louis$93K
- Mark ScheperleSaint Louis$89K
- Shiyang ZhangSaint Louis$45K
- Bernard McGuireSaint Louis$37K
- Daniel GaitanSaint Louis$34K
- Nathan FarkasSaint Louis$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.